Literature DB >> 23833271

Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.

Anniina Snellman1, Francisco R López-Picón, Johanna Rokka, Mario Salmona, Gianluigi Forloni, Mika Scheinin, Olof Solin, Juha O Rinne, Merja Haaparanta-Solin.   

Abstract

UNLABELLED: Follow-up of β-amyloid (Aβ) deposition in transgenic mouse models of Alzheimer disease (AD) would be a valuable translational tool in the preclinical evaluation of potential antiamyloid therapies. This study aimed to evaluate the ability of the clinically used PET tracer (11)C-Pittsburgh compound B ((11)C-PIB) to detect changes over time in Aβ deposition in the brains of living mice representing the APP23, Tg2576, and APP(swe)-PS1(dE9) transgenic mouse models of AD.
METHODS: Mice from each transgenic strain were imaged with 60-min dynamic PET scans at 7-9, 12, 15, and 18-22 mo of age. Regional (11)C-PIB retention was quantitated as distribution volume ratios using Logan graphical analysis with cerebellar reference input, as radioactivity uptake ratios between the frontal cortex (FC) and the cerebellum (CB) during the 60-min scan, and as bound-to-free ratios in the late washout phase (40-60 min). Ex vivo autoradiography experiments were performed after the final imaging session to validate (11)C-PIB binding to Aβ deposits. Additionally, the presence of Aβ deposits was evaluated in vitro using staining with thioflavin-S and Aβ1-40, Aβ1-16, and AβN3(pE) immunohistochemistry.
RESULTS: Neocortical (11)C-PIB retention was markedly increased in old APP23 mice with large thioflavin-S-positive Aβ deposits. At 12 mo, the Logan distribution volume ratio for the FC was 1.03 and 0.93 (n = 2), increasing to 1.38 ± 0.03 (n = 3) and 1.34 (n = 1) at 18 and 21 mo of age, respectively. An increase was also observed in bound-to-free ratios for the FC between young (7- to 12-mo-old) and old (15- to 22-mo-old) APP23 mice. Binding of (11)C-PIB to Aβ-rich cortical regions was also evident in ex vivo autoradiograms of APP23 brain sections. In contrast, no increases in (11)C-PIB retention were observed in aging Tg2576 or APP(swe)-PS1(dE9) mice in vivo, although in the latter, extensive Aβ deposition was already observed at 9 mo of age with immunohistochemistry.
CONCLUSION: The results suggest that (11)C-PIB binding to Aβ deposits in transgenic mouse brain is highly dependent on the AD model and the structure of its Aβ plaques. Longitudinal in vivo (11)C-PIB uptake studies are possible in APP23 mice.

Entities:  

Keywords:  11C-PIB, Pittsburgh compound B; Alzheimer disease; amyloid imaging; positron emission tomography

Mesh:

Substances:

Year:  2013        PMID: 23833271     DOI: 10.2967/jnumed.112.110163

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  36 in total

1.  Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.

Authors:  Min-Liang Pan; Meenakshi T Mukherjee; Himika H Patel; Bhavin Patel; Cristian C Constantinescu; M Reza Mirbolooki; Christopher Liang; Jogeshwar Mukherjee
Journal:  Synapse       Date:  2016-02-11       Impact factor: 2.562

2.  Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.

Authors:  Xueli Zhang; Yanli Tian; Can Zhang; Xiaoyu Tian; Alana W Ross; Robert D Moir; Hongbin Sun; Rudolph E Tanzi; Anna Moore; Chongzhao Ran
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-21       Impact factor: 11.205

3.  A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss.

Authors:  Samuel Chiquita; Mário Ribeiro; João Castelhano; Francisco Oliveira; José Sereno; Marta Batista; Antero Abrunhosa; Ana C Rodrigues-Neves; Rafael Carecho; Filipa Baptista; Catarina Gomes; Paula I Moreira; António F Ambrósio; Miguel Castelo-Branco
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

4.  Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.

Authors:  Peng Liu; John H Reichl; Eshaan R Rao; Brittany M McNellis; Eric S Huang; Laura S Hemmy; Colleen L Forster; Michael A Kuskowski; David R Borchelt; Robert Vassar; Karen H Ashe; Kathleen R Zahs
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults.

Authors:  Andrew J Aschenbrenner; David A Balota; Chi-Shing Tse; Anne M Fagan; David M Holtzman; Tammie L S Benzinger; John C Morris
Journal:  Neuropsychology       Date:  2014-09-15       Impact factor: 3.295

6.  Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.

Authors:  Claudia Balducci; Simona Mancini; Stefania Minniti; Pietro La Vitola; Margherita Zotti; Giulio Sancini; Mario Mauri; Alfredo Cagnotto; Laura Colombo; Fabio Fiordaliso; Emanuele Grigoli; Mario Salmona; Anniina Snellman; Merja Haaparanta-Solin; Gianluigi Forloni; Massimo Masserini; Francesca Re
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

7.  Whole brain imaging reveals distinct spatial patterns of amyloid beta deposition in three mouse models of Alzheimer's disease.

Authors:  Jennifer D Whitesell; Alex R Buckley; Joseph E Knox; Leonard Kuan; Nile Graddis; Andrew Pelos; Alice Mukora; Wayne Wakeman; Phillip Bohn; Anh Ho; Karla E Hirokawa; Julie A Harris
Journal:  J Comp Neurol       Date:  2018-12-04       Impact factor: 3.215

8.  Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion.

Authors:  Florian C Maier; Hans F Wehrl; Andreas M Schmid; Julia G Mannheim; Stefan Wiehr; Chommanad Lerdkrai; Carsten Calaminus; Anke Stahlschmidt; Lan Ye; Michael Burnet; Detlef Stiller; Osama Sabri; Gerald Reischl; Mathias Staufenbiel; Olga Garaschuk; Mathias Jucker; Bernd J Pichler
Journal:  Nat Med       Date:  2014-11-10       Impact factor: 53.440

9.  Preclinical Comparison of the Amyloid-β Radioligands [(11)C]Pittsburgh compound B and [(18)F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis.

Authors:  Ann-Marie Waldron; Jeroen Verhaeghe; Leonie wyffels; Mark Schmidt; Xavier Langlois; Annemie Van Der Linden; Sigrid Stroobants; Steven Staelens
Journal:  Mol Imaging Biol       Date:  2015-10       Impact factor: 3.488

10.  A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain.

Authors:  Sergey V Matveev; Hans Peter Spielmann; Brittney M Metts; Jing Chen; Fredrick Onono; Haining Zhu; Stephen W Scheff; Lary C Walker; Harry LeVine
Journal:  J Neurochem       Date:  2014-07-28       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.